U.S., Jan. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07325409) titled 'Sports Nutrition Benefits of Weizmannia Coagulans BC99' on Dec. 24, 2025.
Brief Summary: To evaluate the clinical efficacy of Weizmannia coagulans BC99 in young Chinese patients with exercise-induced muscle damage compared with placebo, and to explore its effects on inflammatory responses and intestinal microbiota.
Study Start Date: Nov. 01, 2023
Study Type: INTERVENTIONAL
Condition:
College Students of the School of Physical Education
Intervention:
DIETARY_SUPPLEMENT: Placebo
The experimental phase of this study lasts 12 weeks and each participant will have 3 visits (week 0, week 6, week 12)
DIETARY_SUPPLEMENT: BC99
The exp...